STRO — SUTRO BIOPHARMA INC

Ownership history in Kynam Capital Management, LP  ·  13 quarters on record

This page tracks every 13F SEC filing in which Kynam Capital Management, LP reported a position in SUTRO BIOPHARMA INC (STRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.18% (2024 Q1)
Avg. % of fund
0.6%
First filed
2022 Q4
Last filed
2025 Q4
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 479,590 -4,608,509 -90.6% 0.35% $5.5M $11.57
2025 Q3 UNCHANGED 5,088,099 — 0% 0.33% $4.4M $8.70
2025 Q2 REDUCED 5,088,099 -353,348 -6.5% 0.39% $3.6M $7.10
2025 Q1 ADDED 5,441,447 +1,800,000 +49.4% 0.30% $3.5M $6.50
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    STRO price (monthly, adj. close)

Other funds also holding STRO

As of 2025 Q4 — sorted by position size

Velan Capital Investment Management LP 3Y 2.09% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.53% Affinity Asset Advisors, LLC 3Y 0.49% Opaleye Management Inc. 3Y 7Y 0.29% Samsara BioCapital, LLC 3Y 7Y 0.24% Eversept Partners, LP 3Y 7Y 0.11% Vestal Point Capital, LP 0.1% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.09% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.08% ADAR1 Capital Management, LLC 0.06%
← Back to Kynam Capital Management, LP Holdings